MiR-370 sensitizes chronic myeloid leukemia K562 cells to homoharringtonine by targeting Forkhead box M1

被引：0
|
作者：
MinRan Zhou
JiPing Zeng
XiaoMing Wang
Qing Guo
Tao Huang
HaiYu Shen
Yue Fu
LiXiang Wang
JiHui Jia
ChunYan Chen
机构：
[1] Qilu Hospital,Department of Hematology
[2] Shandong University School of Medicine,Department of Microbiology/Key Laboratory for Experimental Teratology of Chinese Ministry of Education
[3] Shandong University School of Medicine,Department of Biochemistry
[4] Shandong University School of Medicine,Department of Pharmacology
[5] Shandong University School of Medicine,Department of Gastrointestinal Surgery
[6] Jinan Central Hospital,undefined
[7] Shandong University School of Medicine,undefined
来源：
Journal of Translational Medicine | / 11卷
关键词：
miR-370; HHT; Cellular apoptosis; Chronic myeloid leukemia;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] MiR-370 sensitizes chronic myeloid leukemia K562 cells to homoharringtonine by targeting Forkhead box M1
    Zhou, MinRan
    Zeng, JiPing
    Wang, XiaoMing
    Guo, Qing
    Huang, Tao
    Shen, HaiYu
    Fu, Yue
    Wang, LiXiang
    Jia, JiHui
    Chen, ChunYan
    JOURNAL OF TRANSLATIONAL MEDICINE, 2013, 11
  • [2] Activin A induction of erythroid differentiation sensitizes K562 chronic myeloid leukemia cells to a subtoxic concentration of imatinib
    Huang, Yu-Wen
    Lee, Wei-Hwa
    Tsai, Yu-Hui
    Huang, Huei-Mei
    AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY, 2014, 306 (01): : C37 - C44
  • [3] Imatinib derivatives as inhibitors of K562 cells in chronic myeloid leukemia
    Azevedo, Liviane D.
    Bastos, Monica M.
    Vasconcelos, Flavia C.
    Hoelz, Lucas V. B.
    Junior, Floriano P. S.
    Dantas, Rafael F.
    de Almeida, Ana C. M.
    de Oliveira, Andressa Paula
    Gomes, Larissa C.
    Maia, Raquel C.
    Boechat, Nubia
    MEDICINAL CHEMISTRY RESEARCH, 2017, 26 (11) : 2929 - 2941
  • [4] Imatinib derivatives as inhibitors of K562 cells in chronic myeloid leukemia
    Liviane D. Azevedo
    Mônica M. Bastos
    Flávia C. Vasconcelos
    Lucas V. B. Hoelz
    Floriano P. S. Junior
    Rafael F. Dantas
    Ana C. M. de Almeida
    Andressa Paula de Oliveira
    Larissa C. Gomes
    Raquel C. Maia
    Nubia Boechat
    Medicinal Chemistry Research, 2017, 26 : 2929 - 2941
  • [5] miR-506 in patients with chronic myeloid leukemia and its effect on apoptosis of K562 cells
    Chen, Nafei
    Meng, Zhen
    Song, Jiaojie
    Kong, Lingfang
    Zhang, Yehua
    Guo, Suli
    Zhang, Xiaokun
    Lu, Xin
    Jiang, Licai
    Chen, Ran
    Jiao, Zongjiu
    Zhao, Liyun
    AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2021, 13 (08): : 9413 - 9420
  • [6] The miR-203a Regulatory Network Affects the Proliferation of Chronic Myeloid Leukemia K562 Cells
    He, Jinhua
    Han, Zeping
    An, Ziyi
    Li, Yumin
    Xie, Xingyi
    Zhou, Jiabin
    He, Sihua
    Lv, Yubing
    He, Mengling
    Qu, Hong
    Liu, Gexiu
    Li, Yuguang
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2021, 9
  • [7] Anticancer activity of Pupalia lappacea on chronic myeloid leukemia K562 cells
    Ravi, Alvala
    Alvala, Mallika
    Sama, Venkatesh
    Kalle, Arunasree M.
    Irlapati, Vamshi K.
    Reddy, B. Madhava
    DARU-JOURNAL OF PHARMACEUTICAL SCIENCES, 2012, 20
  • [8] Novel Cardenolides: Cytotoxicity against Chronic Myeloid Leukemia K562 cells
    Shuja, Ali Asgher
    Ali, Muhammad
    Faizi, Shaheen
    Simjee, Shabana Usman
    BRITISH JOURNAL OF PHARMACOLOGY, 2023, 180 : 465 - 466
  • [9] Anticancer activity of Pupalia lappacea on chronic myeloid leukemia K562 cells
    Alvala Ravi
    Mallika Alvala
    Venkatesh Sama
    Arunasree M Kalle
    Vamshi K Irlapati
    B Madhava Reddy
    DARU Journal of Pharmaceutical Sciences, 20
  • [10] Tendency of K562 Chronic Myeloid Leukemia Cells Towards Cell Reprogramming
    Aktuna, Acelya Yilmazer
    TURKISH JOURNAL OF HEMATOLOGY, 2018, 35 (04) : 260 - 264
12345